-
Je něco špatně v tomto záznamu ?
Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non- estrogenized ovariectomized female rats
J. Kucerova, D. Vrskova, A. Sulcova
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20035259
Knihovny.cz E-zdroje
- MeSH
- autoaplikace MeSH
- chování zvířat účinky léků MeSH
- estradiol farmakologie MeSH
- intravenózní infuze MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- methamfetamin aplikace a dávkování farmakologie MeSH
- ovarektomie MeSH
- posílení podle programu MeSH
- potkani Wistar MeSH
- stimulanty centrálního nervového systému aplikace a dávkování farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: The female animals were already recorded to respond differently to methamphetamine (MET) abuse than males. This gender dissimilarity may be caused by the influence of estral cycles and different susceptibility to behavioural sensitization. METHODS: Influences of gender and pre-exposure to MET were studied in the rat model of MET intravenous self-administration (IVSA). The fixed ratio (FR) paradigm was employed in male rats (M) and estrogenized (F-ESTR) and non-estrogenized ovariectomized female rats (F-OVX) either pre-exposed or not-exposed to MET pretreatment. RESULTS: In rats that were not pre-exposed to MET, F-ESTR self-administered more MET infusions than each of the other groups, but F-OVX self-administered less than each of the other groups; the same trend was apparent in the MET pretreated groups. MET pre-exposure decreased subsequent MET IVSA in all groups except F-OVX. CONCLUSION: Thus, pre-exposure to MET and the loss of inherent estrogen in females notably decreased the intake of MET by rats, suggesting that abuse liability was reduced. Estrogen's effects on MET self-administration here correspond with accumulating evidence of stronger behavioural responses of females to drugs of abuse.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025353
- 003
- CZ-PrNML
- 005
- 20130210202612.0
- 007
- ta
- 008
- 120816s2009 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20035259
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Rudá Kučerová, Jana, $d 1980- $7 xx0068341 $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. jkucer@med.muni.cz
- 245 10
- $a Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non- estrogenized ovariectomized female rats / $c J. Kucerova, D. Vrskova, A. Sulcova
- 520 9_
- $a OBJECTIVE: The female animals were already recorded to respond differently to methamphetamine (MET) abuse than males. This gender dissimilarity may be caused by the influence of estral cycles and different susceptibility to behavioural sensitization. METHODS: Influences of gender and pre-exposure to MET were studied in the rat model of MET intravenous self-administration (IVSA). The fixed ratio (FR) paradigm was employed in male rats (M) and estrogenized (F-ESTR) and non-estrogenized ovariectomized female rats (F-OVX) either pre-exposed or not-exposed to MET pretreatment. RESULTS: In rats that were not pre-exposed to MET, F-ESTR self-administered more MET infusions than each of the other groups, but F-OVX self-administered less than each of the other groups; the same trend was apparent in the MET pretreated groups. MET pre-exposure decreased subsequent MET IVSA in all groups except F-OVX. CONCLUSION: Thus, pre-exposure to MET and the loss of inherent estrogen in females notably decreased the intake of MET by rats, suggesting that abuse liability was reduced. Estrogen's effects on MET self-administration here correspond with accumulating evidence of stronger behavioural responses of females to drugs of abuse.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a stimulanty centrálního nervového systému $x aplikace a dávkování $x farmakologie $7 D000697
- 650 _2
- $a estradiol $x farmakologie $7 D004958
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intravenózní infuze $7 D007262
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methamfetamin $x aplikace a dávkování $x farmakologie $7 D008694
- 650 _2
- $a ovarektomie $7 D010052
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a posílení podle programu $7 D012055
- 650 _2
- $a autoaplikace $7 D012646
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vršková, Dagmar, $d 1978- $7 xx0051019
- 700 1_
- $a Šulcová, Alexandra, $d 1945- $7 jn20000402920
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30, č. 5 (2009), s. 663-670
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20035259 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130210202811 $b ABA008
- 999 __
- $a ok $b bmc $g 947395 $s 782699
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 30 $c 5 $d 663-670 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120816/10/02